Active Ingredient History

NOW
  • Now
Alovudine (fluorothymidine) is an antiviral agent which was being developed by Medivir. It was discontinued after a Phase II trial in 2005 due to toxicity. It is a DNA polymerase inhibitor.   Wikipedia

  • SMILES: CC1=CN([C@H]2C[C@H](F)[C@@H](CO)O2)C(=O)NC1=O
  • InChIKey: UXCAQJAQSWSNPQ-XLPZGREQSA-N
  • Mol. Mass: 244.22
  • ALogP: -0.54
  • ChEMBL Molecule:
More Chemistry
1-(3'-fluoro-3'-deoxy-beta-d-erythropentofuranosyl)thymine | (18f)3'-deoxy-3'-fluorothymidine | (18f)flt | 18f flt | 18f-flt | (18)flt cpd | 3'-deoxy-3'-(18f)fluorothymidine | 3'-deoxy-3'-fluorothymidine | 3'-(f-18)fluoro-3'-deoxythymidine | 3'-fluoro-2',3'-dideoxythymidine | 3'-fluoro-3'-deoxythymidine | 3'-fluorothymidine | alovudine | cl-184824 | fddt

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue